QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study 期刊论文 Endocrine, 2019, 卷号: Vol.63 No.1, 页码: 44-51 作者:  Bao Sun;  Fazhong He;  Lei Sun;  Jiecan Zhou;  Jiayi Shen 收藏  |  浏览/下载：18/0  |  提交时间：2019/02/25 Type  2  diabetes  Major  adverse  cardiovascular  events  Good  glycemic  control  Insufficient  glycemic  control  Poor  glycemic  control   Polytropic Influence of TRIB3 rs2295490 Genetic Polymorphism on Response to Antihypertensive Agents in Patients With Essential Hypertension. 期刊论文 Frontiers in pharmacology, 2019, 卷号: 10, 页码: 236 作者:  Zhou, Jiecan;  He, Fazhong;  Sun, Bao;  Liu, Rong;  Gao, Yongchao 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/27 TRIB3  antihypertensive agents  essential hypertension  polymorphism  rs2295490   GT-WGS: an efficient and economic tool for large-scale WGS analyses based on the AWS cloud service 期刊论文 BMC Genomics, 2018, 卷号: 19, 期号: 1, 页码: 959 作者:  Wang, Yiqi;  Li, Gen;  Ma, Mark;  He, Fazhong;  Song, Zhuo* 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/03 AWS  Parallel and distributed computing  Whole-genome sequencing   Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications. 期刊论文 Frontiers in pharmacology, 2018, 页码: 1422 作者:  He Fazhong;  Shu Yan;  Wang Xingyu;  Liu Xin;  Liu Guojing 收藏  |  浏览/下载：8/0  |  提交时间：2019/02/25 cardiovascular  disease  genetic  variation  individualized  drug  therapy  intensive  glucose  control  type  2  diabetes   Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications 期刊论文 Frontiers in Pharmacology, 2018, 卷号: Vol.9 作者:  Fazhong He;  Yan Shu;  Xingyu Wang;  Xin Liu;  Guojing Liu 收藏  |  浏览/下载：16/0  |  提交时间：2019/02/25 type  2  diabetes  genetic  variation  cardiovascular  disease  individualized  drug  therapy  intensive  glucose  control   Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications 期刊论文 Frontiers in Pharmacology, 2018, 卷号: Vol.9 作者:  Fazhong He;  Yan Shu;  Xingyu Wang;  Xin Liu;  Guojing Liu 收藏  |  浏览/下载：2/0  |  提交时间：2019/02/25 type  2  diabetes  genetic  variation  cardiovascular  disease  individualized  drug  therapy  intensive  glucose  control   Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering Treatment 期刊论文 EBioMedicine, 2016, 卷号: 13, 页码: 181-189 作者:  He, Fazhong;  Liu, Mouze;  Chen, Zhangren;  Liu, Guojing;  Wang, Zhenmin 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/03 TRIB3  Type 2 diabetes  Hypertension  Pharmacogenetics  Individualized drug therapy